Barclays
RIME

Barclays’s Algorhythm Holdings RIME Stock Holding History

Barclays’s Portfolio RIME Stock Details RIME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,184
Closed -$9K – 5618
2025
Q1 		$9K Buy
+4,184
New +$28K ﹤0.01% 4878

Other funds holding RIME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays's RIME Position: Q2 2025 in Review

Barclays sold out of Algorhythm Holdings (RIME) in Q2 2025, closing a stake of 4,184 shares — an estimated $9K sold.

Barclays first reported a position in RIME in Q1 2025 and held it in 1 quarter. The position peaked at $9K in Q1 2025. 8 funds tracked by Wall St. Rank hold RIME as of Q2 2025.

  • Barclays reported no remaining Algorhythm Holdings position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 4,184 Algorhythm Holdings shares in Q2 2025, an estimated $9K.
  • Barclays first reported a position in Algorhythm Holdings in Q1 2025 and held it in 1 quarter.
  • Barclays's Algorhythm Holdings position peaked at $9K in Q1 2025.
  • 8 funds tracked by Wall St. Rank held Algorhythm Holdings as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.